skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 467  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: The Lancet remove language: Japanese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
Material Type:
Article
Add to My Research

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study

The Lancet (British edition), 2017-02, Vol.389 (10071), p.834-845 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 25, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31714-7 ;PMID: 28088338 ;CODEN: LANCAO

Full text available

2
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Material Type:
Article
Add to My Research

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892

Full text available

3
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Material Type:
Article
Add to My Research

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

The Lancet (British edition), 2021-05, Vol.397 (10285), p.1625-1636 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00590-0 ;PMID: 33933205

Full text available

4
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Material Type:
Article
Add to My Research

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

The Lancet (British edition), 2013-07, Vol.382 (9889), p.339-352 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 27, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60595-4 ;PMID: 23727170 ;CODEN: LANCAO

Full text available

5
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

The Lancet (British edition), 2016-03, Vol.387 (10022), p.957-967 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 5, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)01225-8 ;PMID: 26724178 ;CODEN: LANCAO

Full text available

6
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

The Lancet (British edition), 2010-05, Vol.375 (9729), p.1875-1884 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 29-Jun 4, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60656-3 ;PMID: 20462635 ;CODEN: LANCAO

Full text available

7
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Material Type:
Article
Add to My Research

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

The Lancet (British edition), 2020-03, Vol.395 (10226), p.795-808 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32008-2 ;PMID: 31492503

Full text available

8
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
Material Type:
Article
Add to My Research

Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study

The Lancet (British edition), 2011-08, Vol.378 (9792), p.684-692 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 20-Aug 26, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60784-8 ;PMID: 21856482 ;CODEN: LANCAO

Full text available

9
World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease
Material Type:
Article
Add to My Research

World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease

The Lancet (British edition), 2021-10, Vol.398 (10310), p.1467-1468 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02144-9 ;PMID: 34597535

Full text available

10
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
Material Type:
Article
Add to My Research

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

The Lancet (British edition), 2009-11, Vol.374 (9702), p.1677-1686 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Nov 14-Nov 20, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61457-4 ;PMID: 19878986 ;CODEN: LANCAO

Full text available

11
Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study
Material Type:
Article
Add to My Research

Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study

The Lancet (British edition), 2016-08, Vol.388 (10045), p.696-704 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 13, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)00378-0 ;PMID: 27233746 ;CODEN: LANCAO

Full text available

12
Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort
Material Type:
Article
Add to My Research

Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort

The Lancet (British edition), 2020-11, Vol.396 (10263), p.1644-1652 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32233-9 ;PMID: 33186534

Full text available

13
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Material Type:
Article
Add to My Research

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

The Lancet (British edition), 2009-04, Vol.373 (9670), p.1175-1182 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;Copyright Elsevier Limited Apr 4-Apr 10, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60447-5 ;PMID: 19329177 ;CODEN: LANCAO

Full text available

14
Rapid mortality falls after risk-factor changes in populations
Material Type:
Article
Add to My Research

Rapid mortality falls after risk-factor changes in populations

The Lancet (British edition), 2011-08, Vol.378 (9793), p.752-753 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;Copyright Elsevier Limited Aug 27-Sep 2, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)62302-1 ;PMID: 21414659 ;CODEN: LANCAO

Full text available

15
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis

The Lancet (British edition), 2015-02, Vol.385 (9970), p.792-798 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 28, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)62052-3 ;PMID: 25467565 ;CODEN: LANCAO

Full text available

16
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
Material Type:
Article
Add to My Research

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913 [Peer Reviewed Journal]

2005 Elsevier Ltd ;Copyright Lancet Ltd. Sep 10-Sep 16, 2005 ;Copyright Elsevier Limited Sep 10, 2005 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(05)67186-3 ;PMID: 16154017 ;CODEN: LANCAO

Full text available

17
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
Material Type:
Article
Add to My Research

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

The Lancet (British edition), 2005-04, Vol.365 (9468), p.1389-1397 [Peer Reviewed Journal]

2005 Elsevier Ltd ;Copyright Lancet Ltd. Apr 16-Apr 22, 2005 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(05)66374-X ;PMID: 15836887 ;CODEN: LANCAO

Full text available

18
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Material Type:
Article
Add to My Research

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

The Lancet (British edition), 2012-08, Vol.380 (9841), p.565-571 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 11-Aug 17, 2012 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61190-8 ;PMID: 22883507 ;CODEN: LANCAO

Full text available

19
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Material Type:
Article
Add to My Research

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

The Lancet (British edition), 2011-10, Vol.378 (9798), p.1231-1243 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 1-Oct 7, 2011 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61215-4 ;PMID: 21872920 ;CODEN: LANCAO

Full text available

20
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
Material Type:
Article
Add to My Research

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

The Lancet (British edition), 2014-08, Vol.384 (9943), p.591-598 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2014 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61212-5 ;PMID: 25131978 ;CODEN: LANCAO

Full text available

Results 1 - 20 of 467  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait